ArticleFEBS open bio2026
Guiding AlphaFold to predict how Munc13-1 opens Syntaxin-1.
Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The SNARE proteins syntaxin-1, synaptobrevin, and SNAP-25 mediate neurotransmitter release by forming SNARE complexes that fuse synaptic vesicles with the plasma membrane. SNARE complex assembly is orchestrated by Munc18-1 and Munc13-1 through a highly regulated pathway that starts with syntaxin-1 folded into a closed conformation and bound to Munc18-1. It is well-established that Munc13-1 opens syntaxin-1, likely acting catalytically, and that this step is crucial for neurotransmitter release. However, the underlying molecular mechanism remains unknown because it is difficult to obtain structural information on Munc13-1-syntaxin-1 interactions experimentally. Initial attempts with AlphaFold using the syntaxin-1 cytoplasmic region yielded structures of Munc13-1-syntaxin-1 complexes but syntaxin-1 remained closed. Interestingly, when using a shorter syntaxin-1 fragment designed to destabilize the closed conformation, AlphaFold generated a model of Munc13-1 bound to an open syntaxin-1 conformation that explains abundant experimental data and suggests an attractive hypothesis of how Munc13-1 opens syntaxin-1. These results indicate that a judicious selection of protein fragments can help AlphaFold to predict structures of kinetic intermediates in complex biomolecular processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.